Related references
Note: Only part of the references are listed.Reduction in Fluoroquinolone Use following Introduction of Ertapenem into a Hospital Formulary Is Associated with Improvement in Susceptibility of Pseudomonas aeruginosa to Group 2 Carbapenems: a 10-Year Study
Paul P. Cook et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Impact of antimicrobial stewardship in critical care: a systematic review
Reham Kaki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Risk Factors for Mortality in Patients with Pseudomonas aeruginosa Bacteremia: Clinical Impact of Antimicrobial Resistance on Outcome
Eun-Jeong Joo et al.
MICROBIAL DRUG RESISTANCE (2011)
Microbial Etiologies of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Ronald N. Jones
CLINICAL INFECTIOUS DISEASES (2010)
Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006-2008
Alexander J. Kallen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Relationship of Carbapenem Restriction in 22 University Teaching Hospitals to Carbapenem Use and Carbapenem-Resistant Pseudomonas aeruginosa
Amy L. Pakyz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008)
Paul R. Rhomberg et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: A 5-year stury, 2000-2004
Amen Allah Messadi et al.
BURNS (2008)
Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents
Paul P. Cook et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
Timothy H. Dellit et al.
CLINICAL INFECTIOUS DISEASES (2007)
Prescription of antibiotic agents in Swedish intensive care units is empiric and precise
Marcus Erlandsson et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Antibiotic prescription practice in an intensive care unit using twice-weekly collection of screening specimens: a prospective audit in a large UK teaching hospital
MM Warren et al.
JOURNAL OF HOSPITAL INFECTION (2005)
Impact of restricting fluoroquinolone prescription on bacterial, resistance in an intensive care unit
G Aubert et al.
JOURNAL OF HOSPITAL INFECTION (2005)
Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram
PP Cook et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002
MD Obritsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital:: an 8-year-experience:: 1995-2002
JF Mohr et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Unnecessary use of antimicrobials in hospitalized patients - Current patterns of misuse with an emphasis on the antianaerobic spectrum of activity
MT Hecker et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use
MM Neuhauser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Consumption of imipenem correlates with β-lactam resistance in Pseudomonas aeruginosa
PM Lepper et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients
AD Harris et al.
CLINICAL INFECTIOUS DISEASES (2002)
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
DM Livermore
CLINICAL INFECTIOUS DISEASES (2002)
Carbapenem resistance mechanisms in Pseudomonas aeruginosa clinical isolates
H Pai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
